Hospital- and Community-Based Screenings for Hepatocellular Carcinoma in Taiwan
Authors:
- Sheng-Nan LuSLSheng-Nan Lu
- 1 December 2011
- journal article
- Published by S. Karger AG in Oncology
- Vol. 81 (Suppl. 1) , 36-40
Abstract
In Taiwan, hepatocellular carcinoma (HCC) has been the leading cause of cancer incidence and mortality in recent decades. The majority of patients have hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. The HBV carrier rate and incidence of HCC in children have declined with the implementation of a hepatitis B vaccination program for newborns since 1984. A combination of α-fetoprotein and ultrasonography (US) has been used for surveillance in patients with chronic HBV and HCV infection in intervals of 3–6 and 6–12 months for cirrhosis and chronic liver disease, respectively. A secular survival improvement in HCC patients has been demonstrated. A reasonable screening protocol should include two stages. The first stage is identification of high-risk subjects and the second stage is US screening of high-risk subjects. Community-based HCC screening programs have been conducted for more than two decades in Taiwan. The commonly used first-stage markers are HBsAg and anti-HCV, while the platelet count should be a useful marker in HCV-endemic communities. The benefit of HCC screening was shown by a prolonged overall survival. However, this was limited to the early curable stage in elderly subjects. Prevention and control of HCC have multiple modalities. Identification of a high-risk group for active surveillance, effective antiviral treatment for chronic HBV and HCV infection, and early detection and prompt treatment of HCC should decrease the sequelae of HCC in Taiwan.Keywords
This publication has 27 references indexed in Scilit:
- Incidence and associated risk factors of hepatocellular carcinoma in a dural hepatitis B and C virus endemic area: A surveillance studyThe Kaohsiung Journal of Medical Sciences, 2011
- Community‐based screening for hepatocellular carcinoma in elderly residents in a hepatitis B‐ and C‐endemic areaJournal of Gastroenterology and Hepatology, 2010
- Stable seroepidemiology of hepatitis B after universal immunization in Taiwan: A 3-year study of national surveillance of primary school studentsVaccine, 2010
- Optimal treatment increased survival of hepatocellular carcinoma patients detected with community‐based screeningJournal of Gastroenterology and Hepatology, 2010
- Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosisEuropean Journal of Cancer, 2010
- Community-Based Mass Ultrasonographic Screening of Hepatocellular Carcinoma among Thrombocytopenic AdultsCancer Epidemiology, Biomarkers & Prevention, 2008
- The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma – Survival analysis of 3892 patientsEuropean Journal of Cancer, 2008
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in TaiwanInternational Journal of Cancer, 2001
- Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV statusJournal of Hepatology, 2001